Clinical Trials - Horizon Trial and Notification

All Clinical Trials

Filter Trials

Breast Cancer, Cancer

Not Applicable

Interventional Study

A Combined Exercise Training Program for Women Living With Breast Cancer

Sponsor

University of Toronto

Start Date

01/05/2023

Completion Date

30/09/2023

Sex

WOMEN

Enrollment

Ages From

Healthy Volunteers?

Yes

Breast Cancer, Cancer

Phase 2

Interventional Study

TACTIVE-U: A Study to Learn About the Study Medicine (Called ARV-471) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)

Sponsor

Pfizer

Start Date

01/03/2023

Completion Date

06/04/2026

Sex

ALL

Enrollment

Ages From

Healthy Volunteers?

Breast Cancer, Cancer

Phase 2

Interventional Study

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

Sponsor

Canadian Cancer Trials Group

Start Date

27/01/2023

Completion Date

31/12/2027

Sex

ALL

Enrollment

484

Ages From

Healthy Volunteers?

Lung Cancer

Phase 2

Interventional Study

An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)

Sponsor

University Health Network, Toronto

Start Date

04/06/2021

Completion Date

05/12/2024

Sex

ALL

Enrollment

Ages From

Healthy Volunteers?

Yes

Lung Cancer

Not Applicable

Interventional Study

Chest Lymph Node Sampling in Patients With Advanced Lung Cancer to be Treated With Curative-intent Radiation Treatment

Sponsor

Lawson Health Research Institute

Start Date

09/11/2021

Completion Date

31/05/2023

Sex

ALL

Enrollment

Ages From

Healthy Volunteers?

Lung Cancer

Not Applicable

Interventional Study

Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT)

Sponsor

University Health Network, Toronto

Start Date

02/02/2013

Completion Date

01/12/2024

Sex

ALL

Enrollment

150

Ages From

Healthy Volunteers?

Cancer, Lung Cancer

Not Applicable

Interventional Study

18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer

Sponsor

University Health Network, Toronto

Start Date

01/12/2014

Completion Date

30/09/2023

Sex

ALL

Enrollment

Ages From

Healthy Volunteers?

Yes

All Clinical Trials

Filter Trials

Keyword

Condition

Location

Sex

Breast Cancer, Cancer

Not Applicable

Interventional Study

A Combined Exercise Training Program for Women Living With Breast Cancer

Sponsor

Start Date

Completion Date

Sex

Enrollment

Ages From

Healthy Volunteers?

Breast Cancer, Cancer

Phase 2

Interventional Study

TACTIVE-U: A Study to Learn About the Study Medicine (Called ARV-471) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study B)

Sponsor

Start Date

Completion Date

Sex

Enrollment

Ages From

Healthy Volunteers?

Breast Cancer, Cancer

Phase 2

Interventional Study

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/​6-inhibitor Resistant ER+/​HER2- Metastatic Breast Cancer

Sponsor

Start Date

Completion Date

Sex

Enrollment

Ages From

Healthy Volunteers?

Lung Cancer

Phase 2

Interventional Study

An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)

Sponsor

Start Date

Completion Date

Sex

Enrollment

Ages From

Healthy Volunteers?

Lung Cancer

Not Applicable

Interventional Study

Chest Lymph Node Sampling in Patients With Advanced Lung Cancer to be Treated With Curative-intent Radiation Treatment

Sponsor

Start Date

Completion Date

Sex

Enrollment

Ages From

Healthy Volunteers?

Lung Cancer

Not Applicable

Interventional Study

Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy (SBRT)

Sponsor

Start Date

Completion Date

Sex

Enrollment

Ages From

Healthy Volunteers?

Cancer, Lung Cancer

Not Applicable

Interventional Study

18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer

Sponsor

Start Date

Completion Date

Sex

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer